PP
CVS icon

Pegasus Partners’s CVS Health CVS Stock Holding History

Pegasus Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,010
Closed -$733K – 158
2017
Q3 		$733K Buy
9,010
+2,520
+39% +$199K 0.17% 127
2017
Q2 		$522K Sell
6,490
-836
-11% -$66K 0.14% 132
2017
Q1 		$575K Sell
7,326
-24,345
-77% -$1.94M 0.24% 99
2016
Q4 		$2.5M Sell
31,671
-98
-0.3% -$7.93K 1.1% 22
2016
Q3 		$2.83M Sell
31,769
-4,170
-12% -$394K 1.34% 22
2016
Q2 		$3.44M Buy
35,939
+895
+3% +$89.2K 1.78% 13
2016
Q1 		$3.63M Buy
35,044
+12,045
+52% +$1.17M 1.97% 11
2015
Q4 		$2.25M Sell
22,999
-330
-1% -$32.3K 1.13% 27
2015
Q3 		$2.25M Sell
23,329
-1,890
-7% -$199K 1.28% 25
2015
Q2 		$2.65M Buy
+25,219
New +$2.58M 1.17% 22

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pegasus Partners's CVS Position: Q4 2017 in Review

Pegasus Partners sold out of CVS Health (CVS) in Q4 2017, closing a stake of 9,010 shares — an estimated $733K sold.

Pegasus Partners first reported a position in CVS in Q2 2015 and held it in 10 quarters. The position peaked at $3.63M in Q1 2016. 1,598 funds tracked by Wall St. Rank hold CVS as of Q4 2017.

  • Pegasus Partners reported no remaining CVS Health position as of Q4 2017 after selling out during the quarter.
  • Pegasus Partners sold 9,010 CVS Health shares in Q4 2017, an estimated $733K.
  • Pegasus Partners first reported a position in CVS Health in Q2 2015 and held it in 10 quarters.
  • Pegasus Partners's CVS Health position peaked at $3.63M in Q1 2016.
  • 1,598 funds tracked by Wall St. Rank held CVS Health as of Q4 2017.

Based on Pegasus Partners's 13F filing for Q4 2017, filed 8 Feb 2018.